Epstein Secrets

ears at the National Institutes of Health as a Howard Hughes Medical Institute-NIH Research Scholar. Agus has had a long and varied career. At the Memorial Sloan-Kettering Cancer Center in New York, he was an attending physician in the Department of Medical Oncology and head of the Laboratory of Tumor Biology. He was also Assistan

is' work with Agus on cancer led to the founding of the University of Southern California Physical Sciences-Oncology Center (USC PS-OC), funded by the National Cancer Institute (NCI). Hillis is the principle investigator of this program. In 1993, with Thinking Machines facing its demise, Hillis wrote about long-term think

the Division of Cancer Treatment and Diagnosis of the National Can- cer Institute (NCI). That changed in the 2000s, when it became

ancer How “exceptionalresponders’ ‘arerevolutionizing treatment for the deadly desease BY KAT MCGOWAN UST LIKE EVERY NEW drug the oncologists at Memorial Sloan-Kettering Cancer Center test- ed against bladder cancer in the last 20 years, this one didn’t seem to be doing any good. For- ty-four people in the study were given everolim

ylvania School of Medicine in 1991. Agus completed his residency training at Johns Hopkins Hospital and completed his oncology fellowship training at the Memorial Sloan-Kettering Cancer Center in New York. He spent two years at the National Institutes of Health as a Howard Hughes Medical Institute-NIH Research Scholar. Agus has had a long

illis’ work with Agus on cancer led to the founding of the University of Southern California Physical Sciences-Oncology Center (USC PS-OC), funded by the National Cancer Institute (NCI). Hillis is the principle investigator of this program. In 1993, with Thinking Machines facing its demise, Hillis wrote about long-term thinkin